NIH-funded research U01 cooperative agreement

Preventing psychosis in people at high risk

Official title: ProNET: Psychosis-Risk Outcomes Network

Funded at Yale University · NIH-11493631 · Data updated 2026-11-12

Using brain scans, genetics, blood tests, speech samples, and smartphone data to predict outcomes and guide care for people with early signs of psychosis.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 8, 2020
Project endMay 31, 2026
Funding year2026
Award (this year)$436,299
NIH project number3U01MH124639-05SC
Project IDNIH-11493631 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people with clinical high-risk features for psychosis (recently emerging attenuated psychotic symptoms, functional decline, or similar risk signs) who can attend in-person visits and use a smartphone for monitoring.

Less likely to help

People who already have a diagnosed full psychotic disorder or those unable/unwilling to complete in-person scans, sample collection, or phone-based monitoring are unlikely to benefit from participation.

What this research studies

If you take part, you would join over 1,000 people who show early warning signs of psychosis across a network of sites and be followed for two years. The project collects MRI and EEG brain scans, genetic and body-fluid samples, speech and language recordings, clinical interviews, and passive smartphone sensor and survey data at several visits. Healthy volunteers will provide comparison data. Participation typically involves clinic visits for scans and tests, providing samples, and using a phone app for short surveys and passive monitoring.

Why it matters

Potential benefit: If successful, this work could help doctors predict which people are most likely to develop psychosis and tailor early, more personalized care.

How similar studies have gone: Smaller CHR cohorts have found promising biomarker signals but results have not reliably predicted outcomes at large scale, so this larger multi-site effort aims to improve reliability.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Woods, Scott W — Yale University
  • Study coordinator: Woods, Scott W

Related research

Other NIH-funded projects on the same topics.

  • Psychosis in diverse settings across the world

    This project studies how psychotic disorders show up and respond to treatment in adults with diverse backgrounds, including populations in Africa, the Caribbean, and other Global South settings.

    NIH research Suny Downstate Medical Center · Brooklyn, United States · NIH-11592428

  • Psychosis in Diverse Settings: Understanding Symptoms and Treatment Across Global South

    A human-facing study will look at how psychotic disorders present and respond to treatment in adults from Africa, the Caribbean, and other Global South settings, using genetic and clinical data.

    NIH research Suny Downstate Medical Center · Brooklyn, United States · NIH-11592427

  • A new online brain-scan-style tool to spot early psychosis risk

    A new online-based set of tasks and a computer model aims to identify people at high risk for developing psychosis earlier and more accurately.

    NIH research Northwestern University · Chicago, United States · NIH-11590585

  • Genetic clues for early-onset psychosis in Latino youth

    This project looks at the genes of young people with early-onset psychosis and compares them with similar youths without psychosis to find genetic factors that contribute to the illness.

    NIH research Boston Children's Hospital · Boston, United States · NIH-11554752

  • Biomarkers to tailor rehab for Veterans with schizophrenia

    A clinician-scientist is developing a brain-based biomarker to guide personalized rehabilitation for Veterans with schizophrenia.

    NIH research VA San Diego Healthcare System · San Diego, United States · NIH-11552825

  • Computational analysis of facial expression in early psychosis

    Aims to develop computer-based measures of facial expression in people at risk for or with schizophrenia to help track symptoms and guide future trials.

    NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-11539126

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.